Abzena, a San Diego-based CDMO and CRO focused on bioconjugates and complex biologics, has welcomed Taylor Boyd as its new ...

“I have left the FDA,” Witten said in an automatic reply to an email from Fierce Biotech. Witten is no longer listed among the CBER’s leadership on an organizational chart that was updated ...

Exosomes Market Exosomes Market is estimated to be valued at USD 222.1 Mn in 2025 and is expected to reach USD 1,284.1 Mn by 2032, exhibiti ...

The National Institutes of Health unveiled a plan on March 6 to move the peer review of grant applications, cooperative agreements and research and development contracts to a central location at the ...

"In 2024, China's economy demonstrated resilience and the effectiveness of overall reform," said national lawmaker Yuan Yuyu, chairman of Medprin Regenerative Medical Technologies Co., Ltd., a ...

According to the latest information released by the Fungicide Resistance Action Committee (FRAC), over 30 fungicide selective targets have been identified and acknowledged in the field of fungicide ...

New camera techniques transform biological imaging In a nutshell Optimizing camera settings can provide better images of ...

We Prosper Together has announced an initial investment of $5 million to support 11 high-impact projects aimed at advancing ...

China just fired back at the US with a massive round of tariffs, export bans, and legal action at the World Trade ...

Interrupted access to the data has already led to worse outcomes and could undermine faith in the U.S. healthcare system, ...

Wolfgang will then provide an overview of our financial performance in 2024 along with the outlook for 2025. We will then hear from our Divisional Heads who will delve into last year's performance of ...

Operator Good morning, and welcome to Ocugen's fourth quarter and full-year 2024 financial results and business update.